0001127602-19-005195.txt : 20190211
0001127602-19-005195.hdr.sgml : 20190211
20190211195928
ACCESSION NUMBER: 0001127602-19-005195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190207
FILED AS OF DATE: 20190211
DATE AS OF CHANGE: 20190211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ratliff John D
CENTRAL INDEX KEY: 0001575951
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 19587230
MAIL ADDRESS:
STREET 1: C/O QUINTILES TRANSNATIONAL HOLDINGS INC
STREET 2: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-02-07
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001575951
Ratliff John D
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
CEO, Covance Drug Development
Common Stock
2019-02-07
4
M
0
1863
A
11261
D
Common Stock
2019-02-07
4
F
0
556
147.46
D
10665
D
Common Stock
40
I
By revocable trust
Common Stock
80
I
By irrevocable trust
Restricted Stock Unit
2019-02-07
4
M
0
1863
0
D
Common Stock
1863
24474
D
Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
Stock withholding to satisfy tax withholding obligations.
In prior Section 16 reports shares were previously also reported in shares shown as directly owned.
The reporting person is not a trustee of the irrevocable trust and disclaims beneficial ownership of the shares.
The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/7/18.
This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Exhibit 24 - Power of Attorney
/s/ Sandra D. van der Vaart, Attorney-in-Fact for John D. Ratliff
2019-02-11
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): EXHIBIT 24
EXHIBIT 24
POWER OF ATTORNEY
-----------------
KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes
and appoints Sandra D. van der Vaart attorney-in-fact and agent, in
connection with the filing for the undersigned on Form 3, Form 4, and Form 5
under the Securities Act of 1934, as amended, including, without limiting
the generality of the foregoing, to sign the Form 3, Form 4, and Form 5 with
respect to the undersigned's holding of and transactions in securities
issued by Laboratory Corporation of America Holdings, in the name and on
behalf of the undersigned as an officer of Laboratory Corporation of America
Holdings, and any amendments to the Form 3, Form 4, or Form 5 and any
instrument, contract, document or other writing, of or in connection with the
Form 3, Form 4, and Form 5 or amendments thereto, and to file the same, with
all exhibits thereto, and other documents in connection therewith, including
this power of attorney, with the Securities and Exchange Commission and any
applicable securities exchange or securities self-regulatory body, granting
unto said attorney-in-fact and agents, each acting alone, full power and
authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming
all that said attorney-in-fact and agents, each acting alone, or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof. This power of attorney shall become effective immediately, and
shall remain in full force and effect until the undersigned is no longer
required to file Forms 3, 4 and 5, with respect to the undersigned's
holdings of and transactions in securities issued by Laboratory Corporation
of America Holdings, unless earlier revoked by the undersigned in a signed
writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has signed these presents this 11th day
of February, 2019.
/s/ John D. Ratliff
----------------------
John . Ratliff